The Ocular Nepafenac market encompasses pharmaceutical products designed to treat pain and inflammation associated with cataract surgery. Nepafenac, a non-steroidal anti-inflammatory drug (NSAID), is administered topically as an eye drop, typically used before and after ophthalmic procedures. The market's steady growth is fundamentally driven by the global aging population, which dire... https://www.databridgemarketresearch.com/